<VariationArchive VariationID="12102" VariationName="NM_000196.4(HSD11B2):c.895_897del (p.Tyr299del)" VariationType="Deletion" Accession="VCV000012102" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2016-10-23" MostRecentSubmission="2016-10-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27141" VariationID="12102">
      <GeneList>
        <Gene Symbol="HSD11B2" FullName="hydroxysteroid 11-beta dehydrogenase 2" GeneID="3291" HGNC_ID="HGNC:5209" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67429801" stop="67437553" display_start="67429801" display_stop="67437553" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67465035" stop="67471455" display_start="67465035" display_stop="67471455" Strand="+" />
          </Location>
          <OMIM>614232</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000196.4(HSD11B2):c.895_897del (p.Tyr299del)</Name>
      <CanonicalSPDI>NC_000016.10:67436677:ACTAC:AC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67436678" stop="67436680" display_start="67436678" display_stop="67436680" variantLength="3" positionVCF="67436677" referenceAlleleVCF="GACT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67470581" stop="67470583" display_start="67470581" display_stop="67470583" variantLength="3" positionVCF="67470580" referenceAlleleVCF="GACT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Y299del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.67436680_67436682del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.67436680_67436682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.67470583_67470585del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.67470583_67470585del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011482.1" sequenceAccession="NG_011482" sequenceVersion="1" change="g.49507_49509del">
            <Expression>NG_011482.1:g.49507_49509del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016549.1" sequenceAccession="NG_016549" sequenceVersion="1" change="g.10548_10550del">
            <Expression>NG_016549.1:g.10548_10550del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000196.4" sequenceAccession="NM_000196" sequenceVersion="4" change="c.895_897del" MANESelect="true">
            <Expression>NM_000196.4:c.895_897del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000187.3" sequenceAccession="NP_000187" sequenceVersion="3" change="p.Tyr299del">
            <Expression>NP_000187.3:p.Tyr299del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212941" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614232.0010" DB="OMIM" />
        <XRef Type="rs" ID="794726670" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000196.4(HSD11B2):c.895_897del (p.Tyr299del) AND Apparent mineralocorticoid excess" Accession="RCV000012884" Version="12">
        <ClassifiedConditionList TraitSetID="3273">
          <ClassifiedCondition DB="MedGen" ID="C0342488">Apparent mineralocorticoid excess</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-23" MostRecentSubmission="2016-10-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15126515</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3273" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6464" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cortisol 11-beta-ketoreductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AME 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Apparent mineralocorticoid excess</ElementValue>
                <XRef ID="Apparent+Mineralocorticoid+Excess/560" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009025" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AME1</ElementValue>
                <XRef Type="MIM" ID="218030" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AME</ElementValue>
                <XRef Type="MIM" ID="218030" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Apparent mineralocorticoid excess (AME) is an autosomal recessive form of low-renin hypertension associated with low aldosterone, metabolic alkalosis, hypernatremia, and hypokalemia. The disorder is due to a congenital defect in 11-beta-hydroxysteroid dehydrogenase type II (HSD11B2) activity, resulting in decreased conversion of biologically active cortisol to inactive cortisone; this defect allows cortisol to act as a ligand for the mineralocorticoid receptor, resulting in sodium retention and volume expansion. There is a favorable therapeutic response to spironolactone (review by Ferrari, 2010).</Attribute>
                <XRef Type="MIM" ID="218030" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="433" />
                <XRef ID="433" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="320" DB="Orphanet" />
              <XRef ID="C0342488" DB="MedGen" />
              <XRef ID="MONDO:0009025" DB="MONDO" />
              <XRef Type="MIM" ID="218030" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33125" SubmissionDate="2016-10-21" DateLastUpdated="2016-10-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614232.0010_APPARENT MINERALOCORTICOID EXCESS" title="HSD11B2, TYR299DEL_APPARENT MINERALOCORTICOID EXCESS" />
        <ClinVarAccession Accession="SCV000033125" DateUpdated="2016-10-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 11-year-old Pakistani girl, born of consanguineous parents, with apparent mineralocorticoid excess (AME; 218030), Lin-Su et al. (2004) found homozygous deletion of the tyr299 (Y299) codon in exon 5 of the HSD11B2 gene. The patient presented at age 9 years with hypertension (225/120 mm Hg), low plasma renin activity, hypokalemic metabolic alkalosis, suppressed aldosterone, and bilateral nephrocalcinosis. She had had a low birth weight compared with her sibs. Biochemical analysis showed an elevated urinary cortisol-to-cortisone metabolites ratio (tetrahydrocortisol and 5-alpha-tetrahydrocortisol/tetrahydrocortisone) of 28 (normal, 0.66-2.44). She had a cortisol secretion rate of 0.43 mg/d (normal, 5-25 mg/d). In vitro expression in CHO cells revealed that this mutation resulted in no activity.</Attribute>
              <Citation>
                <ID Source="PubMed">15126515</ID>
              </Citation>
              <XRef DB="OMIM" ID="218030" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HSD11B2" />
          </GeneList>
          <Name>HSD11B2, TYR299DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">TYR299DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614232.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">APPARENT MINERALOCORTICOID EXCESS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33125" TraitType="Disease" MappingType="Name" MappingValue="APPARENT MINERALOCORTICOID EXCESS" MappingRef="Preferred">
        <MedGen CUI="C0342488" Name="Apparent mineralocorticoid excess" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

